James C, Lewis R, Fakunmoju A, Witt A, Youssef A, Wang X
J Virol. 2024; 98(10):e0102424.
PMID: 39269177
PMC: 11494926.
DOI: 10.1128/jvi.01024-24.
Hwang J, Dittmar J, Kang J, Ocampo T, Evangelopoulos M, Han Z
Nano Lett. 2024; 24(25):7629-7636.
PMID: 38874796
PMC: 11540143.
DOI: 10.1021/acs.nanolett.4c01392.
Roschenko V, Ayoub A, Engelhardt K, Schafer J, Amin M, Preis E
Pharmaceutics. 2023; 15(10).
PMID: 37896172
PMC: 10610306.
DOI: 10.3390/pharmaceutics15102412.
Hill B, Calder A, Flemming J, Guo Y, Gilmore S, Trofa M
Mol Carcinog. 2023; 62(9):1428-1443.
PMID: 37401875
PMC: 10524928.
DOI: 10.1002/mc.23587.
Li D, Thomas C, Shrivastava N, Gersten A, Gadsden N, Schlecht N
J Med Virol. 2022; 95(2):e28388.
PMID: 36477880
PMC: 10168123.
DOI: 10.1002/jmv.28388.
Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches.
Miserocchi G, Spadazzi C, Calpona S, De Rosa F, Usai A, De Vita A
J Pers Med. 2022; 12(6).
PMID: 35743639
PMC: 9224778.
DOI: 10.3390/jpm12060854.
p63 Directs Subtype-Specific Gene Expression in HPV+ Head and Neck Squamous Cell Carcinoma.
Glathar A, Oyelakin A, Gluck C, Bard J, Sinha S
Front Oncol. 2022; 12:879054.
PMID: 35712470
PMC: 9192977.
DOI: 10.3389/fonc.2022.879054.
Oral Cancer Stem Cells: Therapeutic Implications and Challenges.
Shahoumi L
Front Oral Health. 2022; 2:685236.
PMID: 35048028
PMC: 8757826.
DOI: 10.3389/froh.2021.685236.
Metabolic Plasticity and Combinatorial Radiosensitisation Strategies in Human Papillomavirus-Positive Squamous Cell Carcinoma of the Head and Neck Cell Lines.
Wilkie M, Anaam E, Lau A, Rubbi C, Vlatkovic N, Jones T
Cancers (Basel). 2021; 13(19).
PMID: 34638320
PMC: 8507998.
DOI: 10.3390/cancers13194836.
Phytochemicals as Potential Chemopreventive and Chemotherapeutic Agents for Emerging Human Papillomavirus-Driven Head and Neck Cancer: Current Evidence and Future Prospects.
Aggarwal N, Yadav J, Chhakara S, Janjua D, Tripathi T, Chaudhary A
Front Pharmacol. 2021; 12:699044.
PMID: 34354591
PMC: 8329252.
DOI: 10.3389/fphar.2021.699044.
NF-Y Subunits Overexpression in HNSCC.
Bezzecchi E, Bernardini A, Ronzio M, Miccolo C, Chiocca S, Dolfini D
Cancers (Basel). 2021; 13(12).
PMID: 34208636
PMC: 8234210.
DOI: 10.3390/cancers13123019.
Ex Vivo Culture Models to Indicate Therapy Response in Head and Neck Squamous Cell Carcinoma.
Demers I, Donkers J, Kremer B, Speel E
Cells. 2020; 9(11).
PMID: 33238461
PMC: 7700693.
DOI: 10.3390/cells9112527.
Organotypic Co-Cultures as a Novel 3D Model for Head and Neck Squamous Cell Carcinoma.
Engelmann L, Thierauf J, Laureano N, Stark H, Prigge E, Horn D
Cancers (Basel). 2020; 12(8).
PMID: 32824777
PMC: 7463661.
DOI: 10.3390/cancers12082330.
Relative Biological Effectiveness of Carbon Ions for Head-and-Neck Squamous Cell Carcinomas According to Human Papillomavirus Status.
Osu N, Kobayashi D, Shirai K, Musha A, Sato H, Hirota Y
J Pers Med. 2020; 10(3).
PMID: 32722522
PMC: 7565683.
DOI: 10.3390/jpm10030071.
Characteristics of head and neck squamous cell carcinoma cell Lines reflect human tumor biology independent of primary etiologies and HPV status.
Nair T, Thomas T, Yang L, Kakaraparthi B, Morris A, Clark A
Transl Oncol. 2020; 13(10):100808.
PMID: 32574978
PMC: 7317296.
DOI: 10.1016/j.tranon.2020.100808.
The Relationship between Estrogen-Related Signaling and Human Papillomavirus Positive Cancers.
James C, Morgan I, Bristol M
Pathogens. 2020; 9(5).
PMID: 32455952
PMC: 7281727.
DOI: 10.3390/pathogens9050403.
Human Papilloma Virus Increases ΔNp63α Expression in Head and Neck Squamous Cell Carcinoma.
Citro S, Bellini A, Medda A, Sabatini M, Tagliabue M, Chu F
Front Cell Infect Microbiol. 2020; 10:143.
PMID: 32322564
PMC: 7156594.
DOI: 10.3389/fcimb.2020.00143.
Targeting cancer stem cells in squamous cell carcinoma.
Chen D, Wang C
Precis Clin Med. 2019; 2(3):152-165.
PMID: 31598386
PMC: 6770277.
DOI: 10.1093/pcmedi/pbz016.
Pretreatment Dietary Patterns Are Associated with the Presence of Nutrition Impact Symptoms 1 Year after Diagnosis in Patients with Head and Neck Cancer.
Crowder S, Sarma K, Mondul A, Chen Y, Li Z, Pepino M
Cancer Epidemiol Biomarkers Prev. 2019; 28(10):1652-1659.
PMID: 31315911
PMC: 6774815.
DOI: 10.1158/1055-9965.EPI-19-0128.
Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV and HPV Head and Neck Cancers to TNFα, TRAIL, and Radiation Therapy.
Xiao R, An Y, Ye W, Derakhshan A, Cheng H, Yang X
Clin Cancer Res. 2019; 25(21):6463-6474.
PMID: 31266830
PMC: 6825532.
DOI: 10.1158/1078-0432.CCR-18-3802.